ReviewCurrent allergy and asthma reports2013

Clinical consequences of targeting IL-17 and TH17 in autoimmune and allergic disorders.

Keven M Robinson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.